Custodio, Ivan V.
HRN: 27-93-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/14/2025
10/21/2025
IV
2.25g
Every 6hours
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes